Evaluation of Interleukin-18 Production by In Vitro Differentiated Monocytes from Breast Cancer Patients

REFERENCES

• Okamura H, Tsutusui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-y production by T cells. Nature 1995; 378: 88–91.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-18. Methods 1999;19 (1): 121–32.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. IL-18: A Thl-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103 (1): 11–24.
   PubMed Web of Science ®Google Scholar
• Kohno K, Kataoka J, Otsuki T, et al. IFN-y-inducing fac-tor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997; 158: 1541-50.
   Google Scholar
• Matsui K, Yoshimoto T, Tsutsui H, et al. Propionibacterium acnes treatment diminishes CD4+NK1.1+T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 1997; 159: 97–106.
   Google Scholar
• Bazan JF, Timans JC, Kastelein RA. A newly defined interleukin-1? Nature 1996; 79: 591–602.
   Web of Science ®Google Scholar
• Osaki T, Peron JM, Cai Q, et al. IFN-y inducing fac-tor/IL-18 administration mediates IFN-y and IL-12- indepen-dent antitumor effects. J Immunol 1998; 160 (4): 1742–49.
   PubMed Web of Science ®Google Scholar
• Akita K, Ushio S, Ohtsuki T, Tanimoto T, Ikeda M, Kurimoto M. Comparison between the biological and bio-chemical aspects of IL-18 (IFN-gamma-inducing factor) and IL-113. Proc Am Assoc Cancer Res 1997; 38: 357–61.
   Google Scholar
• Coughlin CM, Salhany KE, Wysocka M, et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998; 101 (6): 1441–52.
   PubMed Web of Science ®Google Scholar
• Matory YL, Chen M, Dorfman DM, Williams A, Goedegebuure PS, Eberlein TJ. Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection. Surgery 1995; 118 (2): 251–6.
   PubMed Web of Science ®Google Scholar
• Maemura M, lino Y, Horiguchi J, et al. Effects of inter-feron-alpha on cellular proliferation and adhesion of breast carcinoma cells. Oncol Rep 1999; 6 (3): 557–61.
   PubMed Web of Science ®Google Scholar
• Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S. Virus infection activates IL-1I3 and IL-18 production in human macrophages by a caspase-l-dependent pathway. J Immunol 1999; 162; 7322-29.
   Google Scholar
• Nelson DS, Nelson M, Farram E, Inoue Y. Cancer and subversion of host defences. Aust J Exp Biol Med Sci 1981; 59: 229–62.
   PubMedGoogle Scholar
• Nelson DS, Nelson M, Inoue Y. Some aspects of macrophage-tumor relationships. In: Macrophage biology. Reichard S, Kojima M, (Ed). New York: Alan R Liss, 1985: 833-44.
   Google Scholar
• Pike MC, Snyderman R. Depression of macrophage function by a factor produced by neoplasms: A mechanism for abrogation of immune surveillance. J Immunol 1976; 117: 1243–50.
   PubMed Web of Science ®Google Scholar
• Micallef MJ, Yoshida K, Kawai S, et al. In vivo antitu-mor effects of murine interferon-gamma-inducing factor/inter-leukin-18 in mice bearing syngeneic Meth A sarcoma malig-nant ascites. Cancer Immunol Immunother 1997; 43 (6): 361–7.
   PubMed Web of Science ®Google Scholar
• Oken MM. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–55.
   PubMed Web of Science ®Google Scholar
• Harmer H. In: TNM- Classification of malignancy tumors. Union International Contre le Cancer (UICC) (284 Ed.) Geneva, Switzerland, 1978.
   Google Scholar
• Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 94: 196–202.
   Google Scholar
• Daems WTH, Roos D, Van Der Rhee HJ. The subcel-lular distribution and biochemical properties of peroxidase in monocytes and macrophages. In: Lysosomes in Applied Biology and Therapeutics. Digle JT, Shaw IH, Jacques PJ, eds., Amsterdam, North Holland: Elsevier, 1979: 463-514.
   Google Scholar
• Merendino RA, Arena A, Iannello D, et al. Evaluation of macrophage antiviral activity in patients affected by neopla-sia. Med Onc Tumor Pharmacother 1988; 5: 191–97.
   PubMedGoogle Scholar
• Merendino RA, Arena A, Mancuso G, et al. Modulation of the intrinsic antiviral activity by Escherichia coli endotoxin in macrophages from patients with neoplasia. J Chemother 1991; 3: 16–22.
   PubMed Web of Science ®Google Scholar
• Arena A, Capozza AB, Orlando ME, et al. qIn vitro» effects of lithium chloride on TNF-a and IL-6 production by monocytes of patients affected by breast cancer. J Chemother 1997; 9: 219–26.
   PubMed Web of Science ®Google Scholar
• Merendino RA, Zummo S, Chillemi S, Arena A, Mesiti M, Bonina L. Interferon release by LPS-treated macrophages from patients affected by neoplasia. Giorn Batt Virol Immunol 1989; LXXXII: 17-24.
   Google Scholar
• Merendino RA, Gangemi S, Misefari A, et al. Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients. Immunol Lett 1999; 68: 355–58.
   PubMed Web of Science ®Google Scholar
• Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M. Interleukin-18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngenic mice from transplantation with Meth A sarcoma. Cancer Res 1997; 57: 4557-63.
   Google Scholar
• Martin F, Santolaria F, Batista N, et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 1999; 11 (1): 80–6.
   PubMed Web of Science ®Google Scholar
• Elsasser-Beile U, von Kleist S, Sauther W, Gallati H, Monting JS. Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Br J Cancer 1993; 68 (1): 32–6.
   PubMed Web of Science ®Google Scholar